Using CMV PCR to Diagnose CMV Disease in HIV Patients
Author Information
Author(s): Brantsaeter Arne B, Holberg-Petersen Mona, Jeansson Stig, Goplen Anne K, Bruun Johan N
Primary Institution: Ullevaal University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway
Hypothesis
The study aims to explore the diagnostic utility of CMV quantitative PCR in plasma from HIV and CMV seropositive patients who died during the period 1991–2002.
Conclusion
Quantitative CMV PCR is best used to rule in, rather than to rule out CMV disease in HIV-infected individuals at high risk.
Supporting Evidence
- 51% of patients with CMV disease had detectable viraemia.
- The sensitivity of the test was maximized with a cut-off at 400 copies/mL.
- Specificity and positive predictive value were 100% with a cut-off at 10,000 copies/mL.
Takeaway
This study looked at how well a blood test can find a virus in people with HIV who are very sick. It found that the test is good at confirming the virus is there, but not so good at saying it's not.
Methodology
The study analyzed plasma samples from 125 HIV and CMV seropositive patients who died, using CMV quantitative PCR to assess viraemia.
Potential Biases
The study may have underestimated the specificity of the test as it relied on autopsy results.
Limitations
The study is retrospective and the time intervals between plasma sample collection and diagnosis varied significantly.
Participant Demographics
{"age":{"median":39,"range":"not specified"},"sex":{"male_percentage":83,"female_percentage":17},"risk_category":{"men_who_have_sex_with_men":60,"intravenous_drug_user":17,"other":19,"unknown":4},"CD4_cell_count":{"median":17,"less_than_100":89,"less_than_50":81}}
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website